Announcements Trials

Browse Landscape

Phase

Status

Withdrawn 1 Completed 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Medullary 1

Interventions

vandetanib 2 veliparib 1 pralsetinib 1 ponatinib 1 lutetium Lu 177 dotatate 1 cabozantinib 1 Temozolomide 1 Sorafenib 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Carcinoma, Medullary × pralsetinib × Clear all

NCT04760288 2024-01-05

AcceleRET-MTC

Hoffmann-La Roche

Phase 3 Withdrawn

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡